A randomized clinical trial of app cognitive behavior therapy vs. HealthWatch for obsessive compulsive disorder

一项针对强迫症的应用程序认知行为疗法与 HealthWatch 的随机临床试验

阅读:1

Abstract

App-based cognitive behavioral therapy (app-CBT) addresses many treatment barriers. We randomized 120 U.S. adults with primary OCD (82.4% female, 77.5% White, mean age 40.1) between 7/2021 and 7/2023 to 12-weeks of coach-guided Perspectives (n = 60; app-CBT) or coach-guided HealthWatch (n = 60; an online well-being program). OCD severity (Yale-Brown Obsessive Compulsive Scale; primary outcome) analyzed using a pre-registered mixed linear model showed a trend level group difference at post-treatment (ES = -0.47; p = 0.079). However, results from secondary and sensitivity analyses showed significantly better outcomes in Perspectives after adjusting for baseline differences or varying missing data assumptions (ps < 0.05). Response rates among completers were 65% in Perspectives and 41% in HealthWatch. Perspectives was also associated with greater pre-to-post-treatment improvement in functioning (ES = -0.55; p = 0.014). 83% of completers in Perspectives were mostly/very satisfied and 91% recommended the program vs. 43% and 53% in HealthWatch. Results highlight app-CBT as an effective and feasible treatment option for OCD that addresses dissemination obstacles.Clinicaltrials.gov identifier: NCT04136626 (Registration Date: 10/17/2019).

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。